Cunlin Wang Email & Phone Number
Global development lead - Olverembatinib
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Cunlin Wang Location
- Clarksburg, MD, US
Cunlin Wang Work
- Global development lead - Olverembatinib @ Ascentage Group Pharma (March 2022 - Present)
- VP and Global Head, Safety and Pharmacovigilance @ Ascentage Group Pharma (June 2019 - Present)
- Working group member @ ICH M14 Expert Working Group on assessing safety of medicinal product using real (January 2022 - Present)
- Safety Science Leader @ (April 2018 - June 2019)
- Medical Director (Global Safety) @ Ultragenyx Pharmaceutical Inc. (January 2017 - April 2018)
- Division Director, Division of Epidemiology I @ (November 2013 - December 2016)
- Lead Medical Epidemiologist @ (May 2011 - October 2013)
- Assistant Professor (adjunct) @ (November 2006 - August 2011)
- Lead Medical Epidemiologist and Medical Epidemiologist @ Center for Device and Radiologic Health, US Food and Drug Administration (July 2006 - April 2011)
- Assistant Professor @ Medical College of Virginia (July 2005 - July 2006)
Cunlin Wang Education
- Excellence in Government (EIG) Leadership Program, US Food and Drug Administration 2014-2015
- Johns Hopkins Bloomberg School of Public Health
Doctor of Philosophy (Ph.D.) (Epidemiology and Global Health)
1999-2004 - Johns Hopkins Bloomberg School of Public Health
Certificate (Vaccine Science)
2001-2002 - Chinese Academy of Preventive Medicine
Master's degree (Clinical Epidemiology and Biostatistics)
1995-1998 - Shanxi Medical University
Doctor of Medicine (M.D.)
1989-1994
Cunlin Wang Skills
- Biostatistics
- Clinical Research
- Clinical Trials
- Clinical safety
- Data Analysis
- Drug safety
- Epidemiology
- FDA
- Global Health
- Health Policy
- Infectious Diseases
- Life Sciences
- Medical Device
- Medical Devices
- Medicine
- Oncology
- Pharmacoepidemiology
- Pharmacovigilance
- Program Evaluation
- Public Health
- Research
- SAS
- Statistics
- U.S. Food and Drug Administration (FDA)
- u.s. Food and Drug Administration Fda
- Management
- Healthcare
- u.s. Food and Drug Administration
Cunlin Wang Summary
- Cunlin Wang, based in Clarksburg, MD, US, is currently a Global development lead - Olverembatinib at Ascentage Group Pharma. Cunlin Wang brings experience from previous roles at Ascentage Group Pharma, ICH M14 Expert Working Group on assessing safety of medicinal product using real, Genentech and Ultragenyx Pharmaceutical Inc.. Cunlin Wang holds a 2014 - 2015 Excellence in Government (EIG) Leadership Program, US Food and Drug Administration. With a robust skill set that includes Biostatistics, Clinical Research, Clinical Trials, Clinical safety, Data Analysis and more. Cunlin Wang has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Cunlin Wang?
Find contact details for 700 million professionals.
Others Named Cunlin Wang
Cunlin Wang
Global development lead - Olverembatinib
Clarksburg, MD, US
Cunlin Wang
Director of Human Resources
Shanghai, China
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co